Nonspecific immunoglobulin and granulocyte-macrophage colony-stimulating factor use in complicated varicella zoster: The first case report in a renal transplant recipient [2]

Transplantation

Volumn 81, Issue 5, 2006, Pages 809-810

  Vales Albertos, Luis Jorge ^a   Andrade Sierra, Jorge ^a   Gómez Navarro, Benjamín ^a   Monteón Ramos, Francisco ^a   Rodríguez Pérez, Miguel ^a   Torres Lozano, Carlos ^a   Cueto Manzano, Alfonso M ^a  

^a HOSPITAL DE ESPECIALIDADES   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CYCLOSPORIN A; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HERPES ZOSTER IMMUNOGLOBULIN; IMMUNOGLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

AGITATION; CHICKENPOX; DISORIENTATION; DYSPNEA; FEVER; GRAFT RECIPIENT; HERPES ZOSTER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY GRAFT; LETTER; LIVER DISEASE; LIVING DONOR; LUNG DISEASE; MALAISE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; THROMBOCYTOPENIA; VARICELLA ZOSTER VIRUS; VESICULAR RASH;

ADOLESCENT; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HERPES ZOSTER; HUMANS; IMMUNE TOLERANCE; IMMUNOGLOBULINS, INTRAVENOUS; KIDNEY TRANSPLANTATION; MALE;

EID: 33645079178     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000199269.77248.2f     Document Type: Letter

References (6)

1. Carcao MD, Lau RC, Gupta AA, et al. Sequential use of intravenous and oral acyclovir in the therapy of varicella immunocompromised children. Pediatr Infect Dis 1999; 17: 626-631.
2. Fehr T, Bossart W, Wahl C, Binswanger U. Disseminated varicella infection in adult renal transplant recipients: four cases and review of the literature. Transplantation 2002; 73: 608-611.
3. Chavez T, Lopez M, de Sousa V. et al. Seroprevalence of antibodies against varicella-zoster virus and response to the varicella vaccine in pediatric renal transplant recipients. Pediatr Transplant 2005; 9: 192-196.
4. Hart D. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 1997; 90: 3245-3287.
5. Hartung T. Anti-inflammatory effects of granulocyte colony-stimulating factor. Curr Opin Haematol 1998; 5: 221-225.
6. Krause I, Wu R, Sherer Y, et al. In vitro anti-viral activity of commercial intravenous immunoglobulin preparations - a potential role for adjuvant intravenous immunoglobulin therapy in infectious diseases. Transf Med 2002; 12: 133-139.